Zilgalvis Pēteris
Bioethics Division, DG 1-Legal Affairs, Council of Europe, 67075 Strasbourg, France.
Sci Eng Ethics. 2002 Jul;8(3):277-81. doi: 10.1007/s11948-002-0044-z.
Conflict of interest is an issue that has been put in the spotlight by the commercial application of the new biomedical technologies. This paper presents the approach of the Council of Europe and the binding legal instruments to deal with this problem. The main focus is on the Convention on Human Rights and Biomedicine, and its draft additional Protocol on Biomedical Research.
利益冲突是一个因新生物医学技术的商业应用而备受关注的问题。本文介绍了欧洲委员会处理这一问题的方法以及具有约束力的法律文书。主要关注点是《人权与生物医学公约》及其生物医学研究附加议定书草案。